The identified subgroups are characterized by the enrichment of specific molecular pathways such as EMT, IL6, RTK‐RAS‐PIK3K, and DNA repair in ICC tumors and EGFR, VEGF signaling immune, and integrine‐pathways in ECC. This evidence concerns the gene EGFR and intrahepatic cholangiocarcinoma.